1-7 of 7
Devon J Shedlock, PhD
Close
Sort by
Journal Articles

Phase 1/2 Study of the Safety and Response of P-BCMA-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME) with Novel Therapeutic Strategies

Caitlin L. Costello, MD, Adam D. Cohen, MD, Krina K. Patel, MD, Syed S Ali, MD, Jesus G. Berdeja, MD, Nina Shah, MD, Siddhartha Ganguly, MD, Mehmet Hakan Kocoglu, MD, Mehrdad Abedi, MD, Eric M. Ostertag, MD PhD, Chris E Martin, PhD, Majid Ghoddussi, PhD, Devon J Shedlock, PhD, Joanne McCaigue, M.S., Hamid Namini, PhD, Sreeni Yalamanchili, Matthew A. Spear, MD, Tara K. Gregory, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-142695
Published: 2020
Journal Articles

Manufacture of an Allogeneic CAR-T Stem Cell Memory Product Candidate for Multiple Myeloma, P-Bcma-ALLO1, Is Robust, Reproducible and Highly Scalable

Stacey A Cranert, PhD, Maximilian Richter, PhD, Min Tong, MS, Leslie Weiss, MS, Yening Tan, MS, Eric M. Ostertag, MD PhD, Julia Coronella, PhD, Devon J Shedlock, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4445.
https://doi.org/10.1182/blood-2019-131839
Published: 2019
Journal Articles

Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)

Caitlin L. Costello, MD, Tara K. Gregory, MD, Syed Abbas Ali, MD, Jesus G. Berdeja, MD, Krina K. Patel, MDMSc, Nina D. Shah, MD, Eric Ostertag, Chris Martin, Majid Ghoddusi, PhD DVM, Devon J Shedlock, PhD, Matthew A. Spear, MD, Robert Z. Orlowski, MD, PhD, Adam D. Cohen, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3184.
https://doi.org/10.1182/blood-2019-129562
Published: 2019
Journal Articles

Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Tara Gregory, MD, Adam D. Cohen, MD, Caitlin L. Costello, MD, Syed Abbas Ali, MD, Jesus G. Berdeja, MD, Eric M Ostertag, MD PhD, Christopher Martin, PhD, Devon J Shedlock, PhD, Michelle Lynn Resler, BS, Matthew A. Spear, MD, Robert Z. Orlowski, MD PhD, Krina K. Patel, MDMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1012.
https://doi.org/10.1182/blood-2018-99-111419
Published: 2018
Journal Articles

A Novel Bcma-Specific, Centyrin-Based CAR-T Product for the Treatment of Multiple Myeloma

David L. Hermanson, PhD, Burton Earle Barnett, PhD, Srinivas Rengarajan, M.S., Rebecca Codde, B.S., Xinxin Wang, PhD, Yening Tan, B.S., Christopher E. Martin, PhD, Jenessa Barbara Smith, PhD, Jin He, M.S., Rohit Mathur, PhD, Jing Yan, PhD, Sattva S. Neelapu, MD, Eric M. Osertag, MD PhD, Devon J. Shedlock, PhD
Journal: Blood
Blood (2016) 128 (22): 2127.
https://doi.org/10.1182/blood.V128.22.2127.2127
Published: 2016
Journal Articles

piggyBac TM -Produced CAR-T Cells Exhibit Stem-Cell Memory Phenotype

Burton Earle Barnett, PhD, David L. Hermanson, PhD, Jenessa Barbara Smith, PhD, Xinxin Wang, PhD, Yening Tan, B.S., Christopher E. Martin, PhD, Eric M. Osertag, MD PhD, Devon J. Shedlock, PhD
Journal: Blood
Blood (2016) 128 (22): 2167.
https://doi.org/10.1182/blood.V128.22.2167.2167
Published: 2016
Journal Articles

Development of Novel Non-Immunoglobulin Centyrin-Based Cars (CARTyrins) Targeting Human Bcma

Burton Earle Barnett, PhD, Xinxin Wang, PhD, David L. Hermanson, PhD, Yening Tan, B.S., Eric M. Osertag, MD PhD, Devon J. Shedlock, PhD
Journal: Blood
Blood (2016) 128 (22): 4557.
https://doi.org/10.1182/blood.V128.22.4557.4557
Published: 2016